Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Canine CCN Family Member 3 (CCN3), C-His

Product Overview

BioVenic's Recombinant Canine CCN Family Member 3 (CCN3), C-His is a recombinant protein expressed from HEK293 Cells. Its predicted molecular weight is 36.9 kDa. The purity is>85% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL).

Specifications

Type Recombinant Protein

Species Canine

Expression System HEK293 Cells

Purity >85% (SDS-PAGE)

Endotoxin <1 EU/μg (LAL)

Predicted Molecular Weight 36.9 kDa

Physical State Lyophilized

Formulation PBS, pH 7.4.

Target Information

Cellular Communication Network Factor 3 (CCN3) is a classical member of the CCN family, known for their shared molecular structures and diverse functionalities. In dogs, CCN3 is encoded by the CCN3 gene. Research indicates that CCN3 plays a significant role in modulating bone turnover and is a novel regulator of skeletal metastasis.

Protein Canine CCN Family Member 3 (CCN3)

Protein Synonym cellular communication network factor 3, NOV, CCN family member 3, nephroblastoma overexpressed, nephroblastoma-overexpressed gene protein, protein NOV

Gene ID 475083

UniProt ID A0A8C0RCV6

Shipping and Storage

This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.

References

Ouellet, V.; Siegel, P. M. CCN3 modulates bone turnover and is a novel regulator of skeletal metastasis. Journal of cell communication and signaling. 2012, 6: 73-85.